observed that promoter DNA methylation significantly reduces tumour suppressor genes BCL2 interacting protein 3 (BNIP3) and BCL2/adenovirus E1B 19 kDa interacting protein 3‐like (BNIP3L) expression in sorafenib‐resistant HCC cells. Here, BNIP3L is linked to hepatocellular carcinoma.